The Bhekisisa Centre for Health Journalism and James Oatway visited George Mukhari academic hospital to document the second-wave realities experienced by doctors and nurses
The HIV prevention tablet is now available in South Africa but popping a pill every day to stay HIV-negative may not be for everyone
Could companies’ wooing of social media influencers be just a clever ploy to get around the country’s tobacco advertising ban?
When kids at risk of suicide can talk to trained friends & family, they’re seven times less likely to die, says one of the world’s largest studies.
Health workers in Mpumalanga fear for their lives because of crime and unsafe buildings
For 25 years, scientists have wondered whether the Depo-Provera could increase people’s risk of contracting HIV. Today, we find out if it does.
We’ve proven Depo Provera doesn’t make it easier to contract HIV. But African women are still left with too few contraceptive choices.
We now know the answer after more than 25 years of guessing, but will women believe it?
Bhekisisa’s latest policy dialogue takes a deep dive into one of the biggest challenges facing SA’s HIV response at the 9th Aids conference.
Small town, big goals: Eshowe has become one of the first SA communities to put enough people on HIV treatment to reduce new infections in the area.